[1]
|
Umehara, H., Okazaki, K., Masaki, Y., et al. (2012) A Novel Clinical Entity, IgG4-Related Disease (IgG4RD): General Concept and Details. Modern Rheumatology, 22, 1-14. https://doi.org/10.3109/s10165-011-0508-6
|
[2]
|
Kamisawa, T., Zen, Y., Pillai, S. and Stone, J.H. (2015) IgG4-Related Disease. Lancet, 385, 1460-1471. https://doi.org/10.1016/S0140-6736(14)60720-0
|
[3]
|
周佳鑫, 张文. 《IgG4相关性疾病诊治中国专家共识》解读[J]. 临床肝胆病杂志, 2021, 37(9): 2062-2065.
|
[4]
|
Khan, M, W., Hadley, T., Kesler, M. and Gul, Z. (2016) Immunoglobulin G4-Related Disease: A Rare Disease with an Unusual Presentation. Clinical Case Reports, 4, 657-660. https://doi.org/10.1002/ccr3.583
|
[5]
|
Kamisawa, T., Funata, N., Hayashi, Y., et al. (2003) A New Clinicopathological Entity of IgG4-Related Autoimmune Disease. Journal of Gastroenterology, 38, 982-984. https://doi.org/10.1007/s00535-003-1175-y
|
[6]
|
Himi, T., Takano, K., Yamamoto, M., et al. (2012) A Novel Concept of Mikulicz’s Disease as IgG4-Related Disease. Auris Nasus Larynx, 39, 9-17. https://doi.org/10.1016/j.anl.2011.01.023
|
[7]
|
Geyer, J.T. and Deshpande, V. (2011) IgG4-Associated Sialadenitis. Current Opinion in Rheumatology, 23, 95-101. https://doi.org/10.1097/BOR.0b013e3283413011
|
[8]
|
Nagai, K., Andoh, K., Ogata, A., et al. (2010) A New Category for Chronic Sclerosing Sialadenitis as an IgG4 Related Syndrome. BMJ Case Reports, 2010, bcr1020092412. https://doi.org/10.1136/bcr.10.2009.2412
|
[9]
|
Inoue, D., Yoshida, K., Yoneda, N., et al. (2015) IgG4-Related Disease: Dataset of 235 Consecutive Patients. Medicine, 94, e680. https://doi.org/10.1097/MD.0000000000000680
|
[10]
|
Lu, H., Teng, F., Zhang, P., et al. (2021) Differences in Clinical Characteristics of IgG4-Related Disease across Age Groups: A Prospective Study of 737 Patients. Rheumatology, 60, 2635-2646. https://doi.org/10.1093/rheumatology/keaa651
|
[11]
|
Wang, L., Zhang, P., Zhang, X., et al. (2019) Sex Disparities in Clinical Characteristics and Prognosis of Immunoglobulin G4-Related Disease: A Prospective Study of 403 Patients. Rheumatology, 58, 820-830. https://doi.org/10.1093/rheumatology/key397
|
[12]
|
汪淼, 侯劲松, 黄洪章, 等. 口腔颌面部IgG4相关硬化性疾病15例临床病理分析[J]. 中华口腔医学研究杂志(电子版), 2012, 6(2): 167-173.
|
[13]
|
Brito-Zerón, P., Ramos-Casals, M., Bosch, X., et al. (2014) The Clinical Spectrum of IgG4-Related Disease. Autoimmunity Reviews, 13, 1203-1210. https://doi.org/10.1016/j.autrev.2014.08.013
|
[14]
|
Wang, Z., Li, W., Hong, X., et al. (2016) Minor Salivary Glands Function Is Decreased in Hyposalivation-Related Diseases. Archives of Oral Biology, 69, 63-70. https://doi.org/10.1016/j.archoralbio.2016.05.012
|
[15]
|
Zen, Y. and Nakanuma, Y. (2011) Pathogenesis of IgG4-Related Disease. Current Opinion in Rheumatology, 23, 114-118. https://doi.org/10.1097/BOR.0b013e3283412f4a
|
[16]
|
Ishikawa, Y. and Terao, C. (2020) Genetic Analysis of IgG4-Related Disease. Modern Rheumatology, 30, 17-23. https://doi.org/10.1080/14397595.2019.1621000
|
[17]
|
Maritati, F., Corradi, D., Versari, A., et al. (2012) Rituximab Therapy for Chronic Periaortitis. Annals of the Rheumatic Diseases, 71, 1262-1264. https://doi.org/10.1136/annrheumdis-2011-201166
|
[18]
|
Lin, W., Zhang, P., Chen, H., et al. (2017) Circulating Plasmablasts/Plasma Cells: A Potential Biomarker for IgG4-Related Disease. Arthritis Research & Therapy, 19, Article No. 25. https://doi.org/10.1186/s13075-017-1231-2
|
[19]
|
Li, J., Liu, Z., Zhang, P., et al. (2021) Peripheral B-Cell Immunophenotyping Identifies Heterogeneity in IgG4-Related Disease. Frontiers in Immunology, 12, Article 747076. https://doi.org/10.3389/fimmu.2021.747076
|
[20]
|
Della-Torre, E., Rigamonti, E., Perugino, C., et al. (2020) B Lymphocytes Directly Contribute to Tissue Fibrosis in Patients with IgG4-Related Disease. Journal of Allergy and Clinical Immunology, 145, 968-981.E14. https://doi.org/10.1016/j.jaci.2019.07.004
|
[21]
|
Akiyama, M., Suzuki, K., Yamaoka, K., et al. (2015) Number of Circulating Follicular Helper 2 T Cells Correlates with IgG4 and Interleukin-4 Levels and Plasmablast Numbers in IgG4-Related Disease. Arthritis & Rheumatology, 67, 2476-2481. https://doi.org/10.1002/art.39209
|
[22]
|
Morita, R., Schmitt, N., Bentebibel, S.E., et al. (2011) Human Blood CXCR5 CD4 T Cells Are Counterparts of T Follicular Cells and Contain Specific Subsets That Differentially Support Antibody Secretion. Immunity, 34, 108-121. https://doi.org/10.1016/j.immuni.2010.12.012
|
[23]
|
Maehara, T., Mattoo, H., Mahajan, V, S., et al. (2018) The Expansion in Lymphoid Organs of IL-4 BATF T Follicular Helper Cells Is Linked to IgG4 Class Switching in Vivo. Life Science Alliance, 1, e201800050. https://doi.org/10.1101/284737
|
[24]
|
Akiyama, M., Suzuki, K., Yoshimoto, K., et al. (2021) Peripheral TIGIT T Follicular Helper Cells That Produce High Levels of Interleukin-21 via OX40 Represent Disease Activity in IgG4-Related Disease. Frontiers in Immunology, 12, Article 651357. https://doi.org/10.3389/fimmu.2021.651357
|
[25]
|
Ito, F., Kamekura, R., Yamamoto, M., et al. (2019) IL-10 T Follicular Regulatory Cells Are Associated with the Pathogenesis of IgG4-Related Disease. Immunology Letters, 207, 56-63. https://doi.org/10.1016/j.imlet.2019.01.008
|
[26]
|
Della-Torre, E., Bozzalla-Cassione, E., Sciorati, C., et al. (2018) A CD8α-Subset of CD4 SLAMF7 Cytotoxic T Cells Is Expanded in Patients with IgG4-Related Disease and Decreases Following Glucocorticoid Treatment. Arthritis & Rheumatology, 70, 1133-1143. https://doi.org/10.1002/art.40469
|
[27]
|
Perugino, C.A., Kaneko, N., Maehara, T., et al. (2021) CD4 and CD8 Cytotoxic T Lymphocytes May Induce Mesenchymal Cell Apoptosis in IgG4-Related Disease. Journal of Allergy and Clinical Immunology, 147, 368-382. https://doi.org/10.1016/j.jaci.2020.05.022
|
[28]
|
Pillai, S., Perugino, C. and Kaneko, N. (2020) Immune Mechanisms of Fibrosis and Inflammation in IgG4-Related Disease. Current Opinion in Rheumatology, 32, 146-151. https://doi.org/10.1097/BOR.0000000000000686
|
[29]
|
Hara, A., Watanabe, T., Minaga, K., et al. (2021) Biomarkers in Autoimmune Pancreatitis and Immunoglobulin G4-Related Disease. World Journal of Gastroenterology, 27, 2257-2269. https://doi.org/10.3748/wjg.v27.i19.2257
|
[30]
|
Furukawa, S., Moriyama, M., Miyake, K., et al. (2017) Interleukin-33 Produced by M2 Macrophages and Other Immune Cells Contributes to Th2 Immune Reaction of IgG4-Related Disease. Scientific Reports, 7, Article No. 42413. https://doi.org/10.1038/srep42413
|
[31]
|
Chinju, A., Moriyama, M., Kakizoe-Ishiguro, N., et al. (2022) CD163 M2 Macrophages Promote Fibrosis in IgG4-Related Disease via Toll-Like Receptor 7/Interleukin-1 Receptor-Associated Kinase 4/NF-κB Signaling. Arthritis & Rheumatology, 74, 892-901. https://doi.org/10.1002/art.42043
|
[32]
|
Furukawa, S., Moriyama, M., Tanaka, A., et al. (2015) Preferential M2 Macrophages Contribute to Fibrosis in IgG4-Related Dacryoadenitis and Sialoadenitis, So-Called Mikulicz’s Disease. Clinical Immunology, 156, 9-18. https://doi.org/10.1016/j.clim.2014.10.008
|
[33]
|
Ono, Y., Kanmura, S., Morinaga, Y., et al. (2017) The Utility of Apoptosis Inhibitor of Macrophages as a Possible Diagnostic Marker in Patients with Crohn’s Disease. BMC Gastroenterology, 17, Article No. 40. https://doi.org/10.1186/s12876-017-0591-z
|
[34]
|
Wu, S. and Wang, H. (2023) IgG4-Related Digestive Diseases: Diagnosis and Treatment. Frontiers in Immunology, 14, Article 1278332. https://doi.org/10.3389/fimmu.2023.1278332
|
[35]
|
Puxeddu, I., Capecchi, R., Carta, F., et al. (2018) Salivary Gland Pathology in IgG4-Related Disease: A Comprehensive Review. Journal of Immunology Research, 2018, Article ID: 6936727. https://doi.org/10.1155/2018/6936727
|
[36]
|
Yu, G, Y., Hong, X., Li, W., et al. (2019) [Clinicopathological Characteristics and Diagnosis of IgG4-Related Sialadenitis]. Journal of Peking University, 51, 1-3.
|
[37]
|
Wang, L., Chu, X., Ma, Y., et al. (2017) A Comparative Analysis of Serum IgG4 Levels in Patients with IgG4-Related Disease and Other Disorders. The American Journal of the Medical Sciences, 354, 252-256. https://doi.org/10.1016/j.amjms.2017.05.009
|
[38]
|
闫雷, 靳德甫, 李畅, 等. 血清IgG4水平对常见自身免疫性疾病的鉴别诊断价值[J]. 中国免疫学杂志, 2022, 38(5): 604-608, 613.
|
[39]
|
Taylor, M.S., Chougule, A., Macleay, A.R., et al. (2019) Morphologic Overlap between Inflammatory Myofibroblastic Tumor and IgG4-Related Disease: Lessons from Next-Generation Sequencing. The American Journal of Surgical Pathology, 43, 314-324. https://doi.org/10.1097/PAS.0000000000001167
|
[40]
|
Sakamoto, M., Moriyama, M., Shimizu, M., et al. (2020) The Diagnostic Utility of Submandibular Gland Sonography and Labial Salivary Gland Biopsy in IgG4-Related Dacryoadenitis and Sialadenitis: Its Potential Application to the Diagnostic Criteria. Modern Rheumatology, 30, 379-384. https://doi.org/10.1080/14397595.2019.1576271
|
[41]
|
Zhang, Y.Y., Hong, X., Wang, Z., et al. (2020) Diagnostic Utility of Submandibular and Labial Salivary Gland Biopsy in IgG4-Related Sialadenitis. Clinical Rheumatology, 39, 3715-3721. https://doi.org/10.1007/s10067-020-05097-1
|
[42]
|
Zhang, X., Jin, X., Guan, L., et al. (2022) IgG4-Related Disease with Gastrointestinal Involvement: Case Reports and Literature Review. Frontiers in Immunology, 13, Article 816830. https://doi.org/10.3389/fimmu.2022.816830
|
[43]
|
李茜, 庞颖, 孙子燕. IgG4相关性腮腺病损的MRI影像学分析[J]. 临床口腔医学杂志, 2022, 38(10): 611-613.
|
[44]
|
Suto, T., Kato, H., Kawaguchi, M., et al. (2022) Reticular Enhancement of the Submandibular Gland on Contrast-Enhanced Magnetic Resonance Imaging in Three Cases with IgG4-Related Chronic Sclerosing Sialadenitis. The Neuroradiology Journal, 35, 243-246. https://doi.org/10.1177/19714009211034475
|
[45]
|
Umehara, H., Okazaki, K., Masaki, Y., et al. (2012) Comprehensive Diagnostic Criteria for IgG4-Related Disease (IgG4-RD), 2011. Modern Rheumatology, 22, 21-30. https://doi.org/10.3109/s10165-011-0571-z
|
[46]
|
Umehara, H., Okazaki, K., Kawa, S., et al. (2021) The 2020 Revised Comprehensive Diagnostic (RCD) Criteria for IgG4-RD. Modern Rheumatology, 31, 529-533. https://doi.org/10.1080/14397595.2020.1859710
|
[47]
|
张盼盼, 张文. IgG4相关性疾病脏器损伤的临床特点、影像学及病理特征[J]. 中华内科杂志, 2016, 55(8): 657-661.
|
[48]
|
Wallace, Z.S., Naden, R.P., Chari, S., et al. (2020) The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis & Rheumatology, 72, 7-19. https://doi.org/10.1002/art.41120
|
[49]
|
Khosroshahi, A., Wallace, Z.S., Crowe, J.L., et al. (2015) International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis & Rheumatology, 67, 1688-1699. https://doi.org/10.1002/art.39132
|
[50]
|
Zhang, K.F., Hong, X., Li, W., et al. (2021) Natural Developing Process of Immunoglobulin G4-Related Sialadenitis after Submandibular Gland Excision: A Retrospective Cohort Study. Clinical Rheumatology, 40, 4969-4976. https://doi.org/10.1007/s10067-021-05859-5
|
[51]
|
Nakayamada, S. and Tanaka, Y. (2023) Development of Targeted Therapies in IgG4-Related Disease. Modern Rheumatology, 33, 266-270. https://doi.org/10.1093/mr/roac096
|
[52]
|
Lin, W., Lu, S., Chen, H., et al. (2015) Clinical Characteristics of Immunoglobulin G4-Related Disease: A Prospective Study of 118 Chinese Patients. Rheumatology, 54, 1982-1990. https://doi.org/10.1093/rheumatology/kev203
|
[53]
|
张文, 董凌莉, 朱剑, 等. IgG4相关性疾病诊治中国专家共识[J]. 中华内科杂志, 2021, 60(3): 192-206.
|
[54]
|
Patel, U., Saxena, A., Patel, D., et al. (2023) Therapeutic Uses of Rituximab and Clinical Features in Immunoglobulin G4-Related Disease: A Systematic Review. Cureus, 15, e45044. https://doi.org/10.7759/cureus.45044
|
[55]
|
Lanzillotta, M., Fernandez-Codina, A., Culver, E., et al. (2021) Emerging Therapy Options for IgG4-Related Disease. Expert Review of Clinical Immunology, 17, 471-483. https://doi.org/10.1080/1744666X.2021.1902310
|